High-fidelity reprogramming into Leydig-like cells by CRISPR activation and paracrine factors.
High-fidelity reprogramming into Leydig-like cells by CRISPR activation and paracrine factors.
复制标题
通过 CRISPR 激活和旁分泌因子高保真重编程为 Leydig 样细胞。
DOI:
10.1093/pnasnexus/pgac179
复制
发表时间:
2022-09
期刊:
影响因子:
--
通讯作者:
Su, Zhijian
中科院分区:
文献类型:
--
作者:
Li, Zhaohui;Fan, Yuxiao;Xie, Cankun;Liu, Jierong;Guan, Xiaoju;Li, Shijun;Huang, Yadong;Zeng, Rong;Chen, Haolin;Su, Zhijian
Abstract Androgen deficiency is a common medical conditions that affects males of all ages. Transplantation of testosterone-producing cells is a promising treatment for male hypogonadism. However, getting a cell source with the characteristics of Leydig cells (LCs) is still a challenge. Here, a high-efficiency reprogramming of skin-derived fibroblasts into functional Leydig-like cells (LLCs) based on epigenetic mechanism was described. By performing an integrated analysis of genome-wide DNA methylation and transcriptome profiling in LCs and fibroblasts, the potentially epigenetic-regulating steroidogenic genes and signaling pathways were identified. Then by using CRISPR/dCas9 activation system and signaling pathway regulators, the male- or female-derived fibroblasts were reprogrammed into LLCs with main LC-specific traits. Transcriptomic analysis further indicated that the correlation coefficients of global genes and transcription factors between LLCs and LCs were higher than 0.81 and 0.96, respectively. After transplantation in the testes of hypogonadal rodent models, LLCs increased serum testosterone concentration significantly. In type 2 diabetic rats model, LLCs which were transplanted in armpit, have the capability to restore the serum testosterone level and improve the hyperglycemia status. In conclusion, our approach enables skin-derived fibroblasts reprogramming into LLCs with high fidelity, providing a potential cell source for the therapeutics of male hypogonadism and metabolic-related comorbidities.
登录
查看更多内容
影响因子:
4.1
作者:
Chen H;Ge RS;Zirkin BR
通讯作者:
Zirkin BR
DOI:
10.1621/nrs.11001
发表时间:
2013
期刊:
Nuclear receptor signaling
影响因子:
--
作者:
Chang C;Yeh S;Lee SO;Chang TM
通讯作者:
Chang TM
影响因子:
2.9
作者:
通讯作者:
--
DOI:
10.1073/pnas.1908207116
发表时间:
2019-11-12
影响因子:
11.1
作者:
Li, Lu;Li, Yuchang;Papadopoulos, Vassilios
通讯作者:
Papadopoulos, Vassilios
影响因子:
5.8
作者:
Bhasin, Shalender;Brito, Juan P.;Yialamas, Maria A.
通讯作者:
Yialamas, Maria A.